Recent changes
- Oct 12, 2026Oct 12, 2026City Therapeutics Sets Terms For ~$175M Nasdaq IPO Pulse story
- Oct 9, 2026Oct 9, 2026IPO ~$175MRumored IPOScoop
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 9, 2026 | ipoRumored | ~$175M | — | IPOScoop |
Latest Pulse
- Oct 13, 2026The IPO Window: Biotech Keeps Pricing, Tech Still WaitsSmall biotech IPOs keep clearing the market while bigger, capital-intensive listings stall: City Therapeutics, TRexBio and Iambic all moved this week while Firmus's $31 billion listing sits withdrawn.→
- Oct 12, 2026City Therapeutics Sets Terms For ~$175M Nasdaq IPOCity Therapeutics set terms for its Nasdaq IPO, offering 9.7 million shares at $17-$19 to raise roughly $175 million, with trading expected to start Friday under the ticker CTY.→
- Oct 9, 2026TRex Bio Prices IPO At $14, Raises $116.7MTRex Bio priced its IPO at $14.00 per share, the low end of its range, selling 8.33 million shares for about $116.7 million before trading began on Nasdaq as TRXB.→
- Sep 28, 2026S-1 Filings Are Piling Up Faster Than PricingsThe SEC logged 12 new S-1 filings and 11 S-1/A or 424B4 amendments in a single late-September window, while only one name -- ADARx -- actually priced (Oura has set a $40-$44 range and is expected to price this week), a widening gap between filing volume and real liquidity.→
Coverage Timeline
newest firstAll Coverage
IPO
The IPO Window: Biotech Keeps Pricing, Tech Still Waits
Small biotech IPOs keep clearing the market while bigger, capital-intensive listings stall: City Therapeutics, TRexBio and Iambic all moved this week while Firmus's $31 billion listing sits withdrawn.
BY THE NUMBERS
City Therapeutics Sets Terms For ~$175M Nasdaq IPO
IPO~$175M IPO
City Therapeutics Sets Terms For ~$175M Nasdaq IPO
City Therapeutics set terms for its Nasdaq IPO, offering 9.7 million shares at $17-$19 to raise roughly $175 million, with trading expected to start Friday under the ticker CTY.
DEEP DIVE
Value Add Research
- VC & Investing · Oct 13, 2026City Therapeutics IPO 2026: $175M Raise, CTY Ticker
- Fundraising · Oct 14, 2026TRexBio IPO 2026: $116.7M Raise, Lilly Eyes Bigger Stake
- Market & Trends · Oct 13, 2026Gravitics IPO 2026: $125M Raise Still Pending (GVTX)
- AI & Technology · Oct 9, 2026Iambic Therapeutics IPO: $150M Raise, $758M Valuation Eyed
- VC & Investing · Sep 30, 2026ADARx IPO: $1.81B Valuation, $446M Raised (ADRX)
- Market & Trends · Jul 10, 2026$5B+ Raised — AI Drug Discovery Startups (2026)
Related Companies
Sources & methodologyshow
Where these figures come from
- IPOScoopValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.